CDK5 and non-small cell lung carcinoma: Liu et al. demonstrated that higher expression of CDK5 was correlated with low/undifferentiated, high pathological stage, lymph node metastasis, shorter median survival, and lower 5-year overall survival in the patients with NSCLC [23].